During the COVID-19 pandemic, we saw the remarkable power of genomics in helping us keep track of new viral variants. Several scientists argue that Africa should continue to invest in genomics to support disease control and public health. Sue Segar asks what this means in practice and why it is considered so critically important.
When renowned geneticist Professor Michèle Ramsay is not building knowledge of African genomic diversity and working on decoding clues for genetic susceptibility to disease, she is knitting a “COVID blanket”. Tiyese Jeranji spoke to her about her passion for genetics, the complexities of genome editing, and how she copes with COVID-19.
Developing COVID-19 vaccines in less than a year came from repurposing multiple, decade-old vaccine research platforms, but too many lives were lost, and a new goal of developing vaccines in 100 days is needed to counter the next global pathogen, experts say.